The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multicenter phase II study of nedaplatin (NP) and irinotecan (CPT) for patients with advanced squamous cell cancer (SCC) of the Lung thoracic Oncology Research Group (TORG 0910).
Haruhiro Saito
No relevant relationships to disclose
Kouzo Yamada
No relevant relationships to disclose
Noriyuki Masuda
No relevant relationships to disclose
Yuichi Takiguchi
No relevant relationships to disclose
Yukio Hosomi
No relevant relationships to disclose
Hiroaki Okamoto
No relevant relationships to disclose
Kazuma Kishi
Research Funding - Daiichi Sankyo
Fumihiro Oshita
No relevant relationships to disclose
Koshiro Watanabe
No relevant relationships to disclose